## **Core Concept**
The question requires selecting a muscle relaxant suitable for a patient with elevated serum bilirubin (indicative of liver dysfunction) and elevated serum creatinine (indicative of kidney dysfunction). The ideal muscle relaxant in this scenario should have minimal hepatic and renal metabolism or excretion.

## **Why the Correct Answer is Right**
Sugammadex is a selective relaxant binding agent (SRBA) that encapsulates steroidal neuromuscular blocking agents like rocuronium and vecuronium, effectively reversing their action. Unlike traditional reversal agents like neostigmine, sugammadex does not rely on renal or hepatic function for its action. It works rapidly and effectively in patients with both liver and kidney dysfunction, making it ideal for patients with compromised hepatic and renal function.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Atracurium is metabolized by Hofmann elimination, a non-enzymatic degradation process that does not require liver or kidney function. However, its metabolite laudanosine can accumulate to potentially toxic levels in patients with severe renal and hepatic impairment, making it less ideal.
* **Option B:** Vecuronium is primarily metabolized by the liver and excreted into the bile, with some metabolites excreted by the kidneys. Its use in patients with significant liver and kidney dysfunction may lead to prolonged neuromuscular blockade.
* **Option D:** Succinylcholine is metabolized rapidly by plasma cholinesterase. While its duration of action is short, it can accumulate to toxic levels in patients with severe renal failure and has other side effects that make it less favorable for patients with multi-organ dysfunction.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that sugammadex is particularly useful in patients with significant renal or hepatic impairment because it provides rapid and effective reversal of neuromuscular blockade without relying on renal or hepatic function.

## **Correct Answer:** . Sugammadex.